Macrolide therapy of group a streptococcal pharyngitis: 10 days of macrolide therapy (clarithromycin) is more effective in streptococcal eradication than 5 days (azithromycin)

Clinical Infectious Diseases

Volumn 32, Issue 12, 2001, Pages 1798-1802

  Kaplan, Edward L ^a   Gooch, W Manfred ^b   Notario, Gerard F ^c   Craft, J Carl ^c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Medical Research Associates   (United States)

^c ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; MACROLIDE;

ADULT; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARYNGITIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD; CLARITHROMYCIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARYNGITIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TREATMENT OUTCOME;

EID: 0035021574     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/320745     Document Type: Article

References (26)

1. Acute pharyngitis: Etiology and diagnosis
2. Streptococcal pharyngitis: Placebo controlled double-blind evaluation of clinical response to penicillin therapy
3. The effect of penicillin therapy on the symptoms and signs of streptococcal pharyngitis
4. The role of the streptococcus in the pathogenesis of rheumatic fever
5. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: A statement for health professionals
6. Diagnosis and management of group A streptococcal pharyngitis: A practice guideline
7. A comparison of azithromycin and penicillin V for the treatment of streptococcal pharyngitis
8. Azithromycin versus penicillin V in the treatment of paediatric patients with acute streptococcal pharyngitis/tonsillitis
9. Five versus ten days' treatment of streptococcal pharyngotonsillitis: A randomized and controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin
10. The pharmacokinetics of azithromycin in human serum and tissues
11. Clarithromycin clinical pharmacokinetics
12. Efficacy of beta-lactamase-resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the pharynx after failure of penicillin therapy for group A streptococcal pharyngitis
13. A comparison of cephalosporins and penicillin in the treatment of group A beta-hemolytic streptococcal pharyngitis: A meta-analysis supporting the concept of microbial copathogenicity
14. Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis
15. Clarithromycin and azithromycin in concise reviews of pediatric infectious diseases
16. Clarithromycin: Where do we go from here?
17. A comparative study of clarithromycin and penicillin VK in the treatment of outpatients with streptococcal pharyngitis
18. Adherence to physicians' instructions as a factor in managing streptococcal pharyngitis
19. Evaluation of the efficacy, safety and toleration of azithromycin vs. penicillin V in the treatment of acute streptococcal pharyngitis in children: Results of a multicenter, open comparative study
20. Macrolides in the management of streptococcal pharyngitis/tonsillitis
21. Multicenter evaluation of azithromycin and penicillin V in the treatment of acute streptococcal pharyngitis and tonsillitis in children
22. Susceptibility of group A beta hemolytic streptococci to thirteen antibiotics: Examination of 301 strains isolated in the United States between 1994 and 1997